Literature DB >> 21740372

Leukocyte- and platelet-rich fibrin (L-PRF) for long-term delivery of growth factor in rotator cuff repair: review, preliminary results and future directions.

Matthias A Zumstein1, Simon Berger, Martin Schober, Pascal Boileau, Richard W Nyffeler, Michael Horn, Clemens A Dahinden.   

Abstract

Surgical repair of the rotator cuff repair is one of the most common procedures in orthopedic surgery. Despite it being the focus of much research, the physiological tendon-bone insertion is not recreated following repair and there is an anatomic non-healing rate of up to 94%. During the healing phase, several growth factors are upregulated that induce cellular proliferation and matrix deposition. Subsequently, this provisional matrix is replaced by the definitive matrix. Leukocyte- and platelet-rich fibrin (L-PRF) contain growth factors and has a stable dense fibrin matrix. Therefore, use of LPRF in rotator cuff repair is theoretically attractive. The aim of the present study was to determine 1) the optimal protocol to achieve the highest leukocyte content; 2) whether L-PRF releases growth factors in a sustained manner over 28 days; 3) whether standard/gelatinous or dry/compressed matrix preparation methods result in higher growth factor concentrations. 1) The standard L-PRF centrifugation protocol with 400 x g showed the highest concentration of platelets and leukocytes. 2) The L-PRF clots cultured in medium showed a continuous slow release with an increase in the absolute release of growth factors TGF-β1, VEGF and MPO in the first 7 days, and for IGF1, PDGF-AB and platelet activity (PF4=CXCL4) in the first 8 hours, followed by a decrease to close to zero at 28 days. Significantly higher levels of growth factor were expressed relative to the control values of normal blood at each culture time point. 3) Except for MPO and the TGFβ-1, there was always a tendency towards higher release of growth factors (i.e., CXCL4, IGF-1, PDGF-AB, and VEGF) in the standard/gelatinous- compared to the dry/compressed group. L-PRF in its optimal standard/gelatinous-type matrix can store and deliver locally specific healing growth factors for up to 28 days and may be a useful adjunct in rotator cuff repair.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21740372     DOI: 10.2174/138920112800624337

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  24 in total

1.  New Biomaterials and Regenerative Medicine Strategies in Periodontology, Oral Surgery, Esthetic and Implant Dentistry.

Authors:  David M Dohan Ehrenfest; Hom-Lay Wang; Jean-Pierre Bernard; Gilberto Sammartino
Journal:  Biomed Res Int       Date:  2015-07-27       Impact factor: 3.411

2.  You are not walking alone in the PRP consensus road.

Authors:  Eduardo Anitua; Mikel Sánchez; Roberto Prado; Gorka Orive; Sabino Padilla
Journal:  Muscles Ligaments Tendons J       Date:  2015-02-05

3.  Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.

Authors:  Michael O Schär; Jose Diaz-Romero; Sandro Kohl; Matthias A Zumstein; Dobrila Nesic
Journal:  Clin Orthop Relat Res       Date:  2015-05       Impact factor: 4.176

4.  The impact of gender and peripheral blood parameters on the characteristics of L-PRF membranes.

Authors:  Catherine Andrade Aldana; Felipe Ugarte Amenabar; Carolina Inostroza Silva; Paulo Diaz Calderon; David Rosenberg Messina; Nelson Pinto Carrasco; Marc Quirynen
Journal:  J Oral Biol Craniofac Res       Date:  2022-09-01

Review 5.  Advances in biologic augmentation for rotator cuff repair.

Authors:  Sahishnu Patel; Anthony P Gualtieri; Helen H Lu; William N Levine
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

Review 6.  Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives.

Authors:  David M Dohan Ehrenfest; Isabel Andia; Matthias A Zumstein; Chang-Qing Zhang; Nelson R Pinto; Tomasz Bielecki
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

7.  Tenocytes, pro-inflammatory cytokines and leukocytes: a relationship?

Authors:  Onays Al-Sadi; Gundula Schulze-Tanzil; Benjamin Kohl; Anke Lohan; Marion Lemke; Wolfgang Ertel; Thilo John
Journal:  Muscles Ligaments Tendons J       Date:  2012-02-15

8.  Biologically based strategies to augment rotator cuff tears.

Authors:  M Schaer; M Schober; S Berger; P Boileau; M A Zumstein
Journal:  Int J Shoulder Surg       Date:  2012-04

9.  Platelet-Rich Product Supplementation in Rotator Cuff Repair Reduces Retear Rates and Improves Clinical Outcomes: A Meta-analysis of Randomized Controlled Trials.

Authors:  James Ryan; Casey Imbergamo; Suleiman Sudah; Greg Kirchner; Patricia Greenberg; James Monica; Charles Gatt
Journal:  Arthroscopy       Date:  2021-03-17       Impact factor: 5.973

10.  Comparative evaluation of platelet-rich fibrin biomaterial and open flap debridement in the treatment of two and three wall intrabony defects.

Authors:  Himanshu Ajwani; Sharath Shetty; Dharmarajan Gopalakrishnan; Rahul Kathariya; Anita Kulloli; R S Dolas; A R Pradeep
Journal:  J Int Oral Health       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.